Celeritas Solutions, LLC

Extend your cash runway without slowing enrollment—bank first savings within 4 weeks. Celeritas Solutions helps CFOs in biotech and life sciences cut clinical trial costs by 10–17%. With over a decade of experience and millions saved for clients, we ensure every trial dollar works harder. Our proprietary Clinical Financial Management (CFM) model brings financial rigor, benchmarking, and expert negotiation to optimize study budgets and free up capital. The impact: faster trials, stronger balance sheets, and more resources to invest in growth. Here’s our bold promise: if we don’t deliver at least a 10x ROI within 6 months, we refund your fees. Guaranteed.

Don’t let CRO scope creep tax your budget—our line-item due diligence recovers hidden dollars. At Celeritas Solutions, we partner with CFOs to cut trial costs by 10–17%, extend cash runway, and accelerate timelines. Our Clinical Financial Management (CFM) model applies the same financial discipline you demand across your enterprise — benchmarking, negotiation, and cost optimization proven to save millions. Plus, we remove risk entirely: If we don’t deliver at least a 10x ROI within 6 months, we refund your fees. Guaranteed. No fine print. Elevate Financial Efficiency – Without Sacrificing Performance. Celeritas delivers measurable savings in as little as 30 days—so impactful, it pays for itself.

You’re Likely Overpaying for Clinical Trials Not because of bad decisions—but because of hidden inefficiencies in CRO pricing and scope. Celeritas uncovers and removes 10–17% in excess cost in weeks. Backed by a 10× ROI guarantee.

Where Is Your Trial Budget Leaking? Most biotech companies are overpaying 10–17% without realizing it. Celeritas uses clinical benchmarking + CRO negotiation to eliminate that waste in ~4 weeks. Guaranteed 10× ROI—or you don’t pay.

You’re Likely Overpaying for Clinical Trials Not because of bad decisions—but because of hidden inefficiencies in CRO pricing and scope. Celeritas uncovers and removes 10–17% in excess cost in weeks. Backed by a 10× ROI guarantee.

You’re Likely Overpaying for Clinical Trials Not because of bad decisions—but because of hidden inefficiencies in CRO pricing and scope. Celeritas uncovers and removes 10–17% in excess cost in weeks. Backed by a 10× ROI guarantee.